Johanna Hynninen
Adjunct professor, MD, Gynecologic oncologist
mijohy@utu.fi ORCID identifier: https://orcid.org/0000-0002-0854-7225 |
Areas of expertise
gynaecologic oncology; ovarian cancer
gynaecologic oncology; ovarian cancer
Research community or research topic
https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu
https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu
Publications 
1 of 5
- Association of clinical and laboratory variables with risk of venous thromboembolism in high-grade serous ovarian cancer (2025)
- International Journal of Gynecological Cancer
(A1 Refereed original research article in a scientific journal) - MUC1 and glycan probing of CA19-9 captured biomarkers from cyst fluids and serum provides enhanced recognition of ovarian cancer (2025)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells (2024)
- Science Advances
(A1 Refereed original research article in a scientific journal) - Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments (2024)
- Cancer Immunology Research
(A1 Refereed original research article in a scientific journal) - Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer (2024)
- Cancer Cell
(A1 Refereed original research article in a scientific journal) - Deciphering cancer genomes with GenomeSpy : a grammar-based visualization toolkit (2024)
- GigaScience
(A1 Refereed original research article in a scientific journal) - Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence (2024)
- Translational Oncology
(A1 Refereed original research article in a scientific journal) - Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma (2024)
- BMC Cancer
(A1 Refereed original research article in a scientific journal) - HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma (2024)
- Gynecologic Oncology
(A1 Refereed original research article in a scientific journal) - Is it safe to operate selected low-risk endometrial cancer patients in secondary hospitals? (2024)
- EJSO - European Journal of Surgical Oncology
(A1 Refereed original research article in a scientific journal) - Kohdunrungon syövän diagnostiikka (2024) Syöpäsairaudet Puistola, Ulla; Mäenpää, Johanna; Staff, Synnöve; Hynninen, Johanna
(D2 Article in a professional compilation book) - Kohdunrungon syövän hoito (2024) Syöpäsairaudet Puistola, Ulla; Mäenpää, Johanna; Lindholm, Paula; Staff, Synnöve; Hynninen, Johanna
(D2 Article in a professional compilation book) - Kohdunrungon syövän yleisyys, vaaratekijät ja esiasteet (2024) Syöpäsairaudet Puistola, Ulla; Mäenpää, Johanna; Staff, Synnöve; Hynninen, Johanna
(D2 Article in a professional compilation book) - Kohtusarkoomat (2024) Syöpäsairaudet Puistola, Ulla; Mäenpää, Johanna; Staff, Synnöve; Hynninen, Johanna
(D2 Article in a professional compilation book) - Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level (2024)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures (2024)
- Neoplasia
(A1 Refereed original research article in a scientific journal) - Trofoblastisairaudet (2024) Syöpäsairaudet Mäenpää, Johanna; Puistola, Ulla; Urpilainen, Elina; Hynninen, Johanna
(D2 Article in a professional compilation book) - Trofoblastisairaudet (2024) Syöpäsairaudet Mäenpää, Johanna; Puistola, Ulla; Urpilainen, Elina; Hynninen, Johanna
(D2 Article in a professional compilation book) - A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids (2023)
- Developmental Cell
(A1 Refereed original research article in a scientific journal) - Circulating tumor DNA-based copy-number profiles enable monitoring treatment effects during therapy in high-grade serous carcinoma (2023)
- Biomedicine and Pharmacotherapy
(A1 Refereed original research article in a scientific journal)
UTU Research Portal